应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02877 神威药业
未开盘 11-25 16:08:41
8.340
+0.210
+2.58%
最高
8.730
最低
8.210
成交量
233.10万
今开
8.250
昨收
8.130
日振幅
6.40%
总市值
68.97亿
流通市值
68.97亿
总股本
8.27亿
成交额
1,970万
换手率
0.28%
流通股本
8.27亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
神威药业(02877)上涨5.17%,报8.55元/股
金融界 · 11-25 11:50
神威药业(02877)上涨5.17%,报8.55元/股
神威药业盘中异动 急速上涨5.17%
市场透视 · 11-25 11:50
神威药业盘中异动 急速上涨5.17%
神威药业(02877)股价上升5.166%,现价港币$8.55
阿斯达克财经 · 11-25 11:50
神威药业(02877)股价上升5.166%,现价港币$8.55
中药饮片拟全国集采 业内人士建议勿仅追求低价
经济观察报 · 11-14
中药饮片拟全国集采 业内人士建议勿仅追求低价
港股异动 | 神威药业(02877)午后跌超4% 前三季度营业额同比减少16.9%
智通财经 · 11-08
港股异动 | 神威药业(02877)午后跌超4% 前三季度营业额同比减少16.9%
神威药业(02877)前三季度营业额28.87亿元 同比减少16.9%
智通财经 · 11-08
神威药业(02877)前三季度营业额28.87亿元 同比减少16.9%
《业绩》神威药业(02877.HK)首九个月营业额约28.8亿人币 按年跌近17%
阿斯达克财经 · 11-08
《业绩》神威药业(02877.HK)首九个月营业额约28.8亿人币 按年跌近17%
神威药业10月28日主力资金流出32万元 连续5日减仓
市场透视 · 10-28
神威药业10月28日主力资金流出32万元 连续5日减仓
神威药业10月24日主力资金流出137万元 连续3日减仓
市场透视 · 10-24
神威药业10月24日主力资金流出137万元 连续3日减仓
格隆汇沽空预警榜 | 10月22日
格隆汇 · 10-24
格隆汇沽空预警榜 | 10月22日
神威药业10月17日遭主力抛售20万元 环比增加400.00%
市场透视 · 10-17
神威药业10月17日遭主力抛售20万元 环比增加400.00%
神威药业盘中异动 大幅下挫5.03%报9.250港元
市场透视 · 10-14
神威药业盘中异动 大幅下挫5.03%报9.250港元
南向资金10月8日净买入神威药业92.90万股 连续5日增持
市场透视 · 10-09
南向资金10月8日净买入神威药业92.90万股 连续5日增持
神威药业10月02日遭主力抛售67万元 环比增加1240.00%
市场透视 · 10-02
神威药业10月02日遭主力抛售67万元 环比增加1240.00%
神威药业盘中异动 早盘股价大涨5.41%
市场透视 · 09-30
神威药业盘中异动 早盘股价大涨5.41%
【ESG动态】神威药业(02877.HK)华证指数ESG最新评级BBB,行业排名第14
证券之星 · 09-16
【ESG动态】神威药业(02877.HK)华证指数ESG最新评级BBB,行业排名第14
南向资金9月4日净买入神威药业4.10万股 连续5日增持
市场透视 · 09-05
南向资金9月4日净买入神威药业4.10万股 连续5日增持
华兴证券:重申神威药业(02877)“买入”评级 目标价下调至18港元
智通财经网 · 09-04
华兴证券:重申神威药业(02877)“买入”评级 目标价下调至18港元
《大行》华兴证券降神威药业(02877.HK)目标价至18元 每股净现金接近股价及维持高分红率
阿斯达克财经 · 09-04
《大行》华兴证券降神威药业(02877.HK)目标价至18元 每股净现金接近股价及维持高分红率
《大行》建银国际降神威药业(02877.HK)目标价至11元 上半年业绩逊
阿斯达克财经 · 09-04
《大行》建银国际降神威药业(02877.HK)目标价至11元 上半年业绩逊
加载更多
公司概况
公司名称:
神威药业
所属市场:
SEHK
上市日期:
--
主营业务:
中国神威药业集团有限公司是一家投资控股公司,主要从事研发、制造及营销现代中药业务。其主要产品包括注射液、软胶囊及颗粒剂。该公司的子公司包括远大国际有限公司、宏展国际有限公司和神威药业营销有限公司。
发行价格:
--
{"stockData":{"symbol":"02877","market":"HK","secType":"STK","nameCN":"神威药业","latestPrice":8.34,"timestamp":1732522121031,"preClose":8.13,"halted":0,"volume":2331000,"delay":0,"floatShares":827000000,"shares":827000000,"eps":1.3784002,"marketStatus":"未开盘","marketStatusCode":0,"change":0.21,"latestTime":"11-25 16:08:41","open":8.25,"high":8.73,"low":8.21,"amount":19703372,"amplitude":0.063961,"askPrice":8.36,"askSize":6000,"bidPrice":8.33,"bidSize":22000,"shortable":3,"etf":0,"ttmEps":1.5680248422068472,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1732584600000},"adr":0,"adjPreClose":8.13,"dividendRate":0.069562,"openAndCloseTimeList":[[1732498200000,1732507200000],[1732510800000,1732521600000]],"volumeRatio":3.439891,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02877","defaultTab":"news","newsList":[{"id":"2486725643","title":"神威药业(02877)上涨5.17%,报8.55元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2486725643","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486725643?lang=zh_cn&edition=full","pubTime":"2024-11-25 11:50","pubTimestamp":1732506634,"startTime":"0","endTime":"0","summary":"11月25日,神威药业(02877)盘中上涨5.17%,截至11:50,报8.55元/股,成交809.82万元。中国神威药业集团有限公司是专注于现代中药研发、生产、销售的大型企业集团,主要操作现代中药新剂型、新产品,着重发展在高速增长的中老年、儿童用药及抗病毒用药的市场。2004年,该公司综合实力跃居全国中成药企业十强,并以清开灵注射液、参麦注射液和心脑清软胶囊成为国内最大生产商,拥有总销售额超过千万元的品种15个,其中3个品种年销售额过亿。截至2024年中报,神威药业营业总收入20.87亿元、净利润6.26亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/11/25115045631117.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02877","BK1606","BK1191"],"gpt_icon":0},{"id":"2486254597","title":"神威药业盘中异动 急速上涨5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486254597","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486254597?lang=zh_cn&edition=full","pubTime":"2024-11-25 11:50","pubTimestamp":1732506632,"startTime":"0","endTime":"0","summary":"2024年11月25日临近午盘11时50分,神威药业股票出现波动,股价大幅上涨5.17%。截至发稿,该股报8.550港元/股,成交量96.6万股,换手率0.12%,振幅4.18%。神威药业股票所在的中医药行业中,整体涨幅为0.10%。其相关个股中,神威药业、现代中药集团、位元堂涨幅较大,振幅较大的相关个股有位元堂、健倍苗苗、神威药业,振幅分别为8.10%、4.43%、3.81%。神威药业公司简介:中国神威药业集团有限公司是一家主要从事中药产品研发、制造及买卖的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112511503298e4451c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112511503298e4451c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1606","BK1191","02877"],"gpt_icon":0},{"id":"2486726686","title":"神威药业(02877)股价上升5.166%,现价港币$8.55","url":"https://stock-news.laohu8.com/highlight/detail?id=2486726686","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486726686?lang=zh_cn&edition=full","pubTime":"2024-11-25 11:50","pubTimestamp":1732506600,"startTime":"0","endTime":"0","summary":"[上升股]神威药业(02877) 股价在上午11:50比前收市价上升5.166%,现股价为港币$8.55。至目前为止,今日最高价为$8.55,而最低价为$8.21。总成交量为96.6万股,总成交金额为港币$809.816万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20190212132919673_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20190212132919673_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2411251155/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02877","BK1606","BK1191"],"gpt_icon":0},{"id":"2483887503","title":"中药饮片拟全国集采 业内人士建议勿仅追求低价","url":"https://stock-news.laohu8.com/highlight/detail?id=2483887503","media":"经济观察报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483887503?lang=zh_cn&edition=full","pubTime":"2024-11-14 19:52","pubTimestamp":1731585152,"startTime":"0","endTime":"0","summary":"经济观察网 记者 张英 11月13日,全国中药饮片联盟采购办公室发布了《全国中药饮片采购联盟集中采购文件(征求意见稿)》,自11月14日起就中药饮片集采问题向社会公开征求意见,意见反馈时间截至11月18日。意见稿显示,本次中药饮片集采涉及丹参、黄芪、连翘、当归、金银花等45个品种。采购周期原则上为1年,视情况可延长不...","market":"us","thumbnail":"https://inews.gtimg.com/om_ls/Ok8jZkMmEPF2CLEc5zrxV-O8CALfitSxzlGbg4oFb5v4cAA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/Ok8jZkMmEPF2CLEc5zrxV-O8CALfitSxzlGbg4oFb5v4cAA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20241114A08EBD00","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20241114A08EBD00","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["02877","BK1606","BK1191","BK1515","00570"],"gpt_icon":0},{"id":"2481115879","title":"港股异动 | 神威药业(02877)午后跌超4% 前三季度营业额同比减少16.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481115879","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481115879?lang=zh_cn&edition=full","pubTime":"2024-11-08 13:32","pubTimestamp":1731043952,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,神威药业(02877)午后跌超4%,截至发稿,跌4.44%,报8.83港元,成交额651.24万港元。消息面上,神威药业午间公告,截至2024年9月30日止9个月未经核数师审阅的管理账目内营业额为人民币28.87亿元,同比减少16.9%,分别是:注射液产品的营业额减少26.7%至人民币10.28亿元;软胶囊产品的营业额减少19.3%至人民币3.91亿元;颗粒剂产品的营业额减少2.2%至人民币4.57亿元;中药配方颗粒产品的营业额减少12.0%至人民币8.24亿元;及其他剂型产品的营业额增加2.6%至人民币1.87亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1208398.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02877","BK1606","BK1191"],"gpt_icon":0},{"id":"2481719437","title":"神威药业(02877)前三季度营业额28.87亿元 同比减少16.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481719437","media":"智通财经","labels":["Business Data"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481719437?lang=zh_cn&edition=full","pubTime":"2024-11-08 12:12","pubTimestamp":1731039140,"startTime":"0","endTime":"0","summary":"以产品剂型分析,截至2024年9月30日止9个月,注射液产品、软胶囊产品、颗粒剂产品及中药配方颗粒产品分别占集团的营业总额约35.6%、13.5%、15.8%及28.5%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1208388.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"Business Data","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02877","BK1606","BK1191"],"gpt_icon":0},{"id":"2481246194","title":"《业绩》神威药业(02877.HK)首九个月营业额约28.8亿人币 按年跌近17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481246194","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481246194?lang=zh_cn&edition=full","pubTime":"2024-11-08 12:07","pubTimestamp":1731038820,"startTime":"0","endTime":"0","summary":"神威药业公布,截至今年9月底止九个月,营业额为28.87亿元人民币(下同),按年跌16.9%。今年首九个月,注射液产品、软胶囊产品、颗粒剂产品及中药配方颗粒产品,分别占集团之营业总额约35.6%、13.5%、15.8%及28.5%。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20210824152732362_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20210824152732362_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1395218/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1606","02877","BK1191"],"gpt_icon":0},{"id":"2478311173","title":"神威药业10月28日主力资金流出32万元 连续5日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2478311173","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478311173?lang=zh_cn&edition=full","pubTime":"2024-10-28 16:16","pubTimestamp":1730103383,"startTime":"0","endTime":"0","summary":"10月28日, 神威药业股价涨1.68%,报收9.71元,成交金额697万元,换手率0.09%,振幅3.46%,量比0.87。神威药业今日主力资金净流出32万元,连续5日净流出,上一交易日主力净流出86万元,今日环比减少62.79%。该股近5个交易日上涨1.57%,主力资金累计净流出407万元;近20日主力资金累计净流出262万元,其中净流出天数为14日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028161648ab7abd0b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028161648ab7abd0b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1606","BK1191","02877"],"gpt_icon":0},{"id":"2477771005","title":"神威药业10月24日主力资金流出137万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2477771005","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477771005?lang=zh_cn&edition=full","pubTime":"2024-10-24 16:16","pubTimestamp":1729757805,"startTime":"0","endTime":"0","summary":"10月24日, 神威药业股价跌3.08%,报收9.44元,成交金额644万元,换手率0.08%,振幅2.57%,量比0.61。神威药业今日主力资金净流出137万元,连续3日净流出,上一交易日主力净流出76万元,今日环比增加80.26%。该股近5个交易日下跌1.05%,主力资金累计净流出128万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流出105万元,其中净流出天数为12日。该股主力净额占比0.02%,港股市场排名2447/2642。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024161713a1e6494e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024161713a1e6494e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02877","BK1606","BK1191"],"gpt_icon":0},{"id":"2477567719","title":"格隆汇沽空预警榜 | 10月22日","url":"https://stock-news.laohu8.com/highlight/detail?id=2477567719","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477567719?lang=zh_cn&edition=full","pubTime":"2024-10-24 02:15","pubTimestamp":1729707300,"startTime":"0","endTime":"0","summary":"格隆汇勾股大数据显示,上一交易日大市沽空比例为13.13%,过去两个月大市日均沽空比例为16.60%。其中,恒生中国企业-R、GX中国机智-U、PP科创50-U沽空比率排名前三位,分别为100.00%、100.00%、100.00%。南方恒生科技、盈富基金、中芯国际的沽空金额排名前三位,分别为22.84亿、11.40亿、6.43亿。兖煤澳大利亚、腾讯音乐-SW、出门问问的偏离值排名前三位,分别为6.14、5.52、5.30。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/10/24021544368229.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1604","09151","01698","82331","02438","02829","03813","BK1231","00981","09807","02800","82318","03033","LU0039217434.USD","00659","80016","LU0048580855.USD","83147","03668","02318","HK0000320264.USD","601318","L","81810","89618","03145","BK1583","02498","03050","00564","LU2097828805.USD","82828","00939","IE00BVYPNP33.GBP","LU0229945570.USD","LU2097828474.EUR","03983","00215","02877","89988","03143"],"gpt_icon":1},{"id":"2476194606","title":"神威药业10月17日遭主力抛售20万元 环比增加400.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476194606","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476194606?lang=zh_cn&edition=full","pubTime":"2024-10-17 16:16","pubTimestamp":1729152997,"startTime":"0","endTime":"0","summary":"10月17日, 神威药业股价涨0.11%,报收9.50元,成交金额1496万元,换手率0.19%,振幅3.79%,量比0.73。神威药业今日主力资金净流出20万元,上一交易日主力净流出4万元,今日环比增加400.00%。该股近5个交易日下跌1.44%,主力资金累计净流出129万元,其中2个交易日为股价上涨时净流出;近20日主力资金累计净流入128万元,其中净流入天数为5日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101716171795aeff58&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101716171795aeff58&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1606","02877"],"gpt_icon":0},{"id":"2475809159","title":"神威药业盘中异动 大幅下挫5.03%报9.250港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475809159","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475809159?lang=zh_cn&edition=full","pubTime":"2024-10-14 10:03","pubTimestamp":1728871414,"startTime":"0","endTime":"0","summary":"2024年10月14日早盘10时03分,神威药业股票出现异动,股价大幅跳水5.03%。截至发稿,该股报9.250港元/股,成交量39.9万股,换手率0.05%,振幅4.31%。资金方面,该股资金流入111.966万港元,流出244.539万港元。神威药业股票所在的中医药行业中,整体跌幅为0.22%。其相关个股中,吉林长龙药业、健倍苗苗、现代中药集团涨幅较大,振幅较大的相关个股有神威药业、福森药业、同仁堂国药,振幅分别为4.31%、4.17%、3.72%。该公司在中国大陆和中国香港市场运营其业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101410033498e3c1fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101410033498e3c1fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02877","BK1191","BK1606"],"gpt_icon":0},{"id":"2474588782","title":"南向资金10月8日净买入神威药业92.90万股 连续5日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2474588782","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474588782?lang=zh_cn&edition=full","pubTime":"2024-10-09 09:30","pubTimestamp":1728437416,"startTime":"0","endTime":"0","summary":"10月8日, 南向资金增持神威药业92.90万股,连续5日增持。截止当日收盘,港股通共持有神威药业2782.50万股,占流通股3.36%。神威药业近5个交易日上涨2.48%,港股通累计增持187.20万股;近20个交易日上涨12.15%,港股通累计增持313.20万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410090933239599703a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410090933239599703a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02877","BK1606","BK1191"],"gpt_icon":0},{"id":"2472515072","title":"神威药业10月02日遭主力抛售67万元 环比增加1240.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472515072","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472515072?lang=zh_cn&edition=full","pubTime":"2024-10-02 16:16","pubTimestamp":1727857002,"startTime":"0","endTime":"0","summary":"10月02日, 神威药业股价涨0.22%,报收9.30元,成交金额1158万元,换手率0.15%,振幅7.11%,量比1.03。神威药业今日主力资金净流出67万元,连续3日净流出,上一交易日主力净流出5万元,今日环比增加1240.00%。该股近5个交易日上涨13.54%,主力资金累计净流出172万元;近20日主力资金累计净流出168万元,其中净流出天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410021618039f24c8fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410021618039f24c8fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1606","BK1191","02877"],"gpt_icon":0},{"id":"2471151568","title":"神威药业盘中异动 早盘股价大涨5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2471151568","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471151568?lang=zh_cn&edition=full","pubTime":"2024-09-30 09:39","pubTimestamp":1727660341,"startTime":"0","endTime":"0","summary":"2024年09月30日早盘09时39分,神威药业股票出现异动,股价大幅拉升5.41%。截至发稿,该股报9.350港元/股,成交量45.8万股,换手率0.06%,振幅5.86%。神威药业股票所在的中医药行业中,整体涨幅为0.15%。其相关个股中,神威药业、同仁堂科技、白云山涨幅较大,振幅较大的相关个股有神威药业、同仁堂科技、白云山,振幅分别为5.86%、5.57%、5.13%。消息层面,截至09时39分,神威药业股票正面舆情新闻比例100%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409300939019719d4d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409300939019719d4d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1606","BK1191","02877"],"gpt_icon":0},{"id":"2467854874","title":"【ESG动态】神威药业(02877.HK)华证指数ESG最新评级BBB,行业排名第14","url":"https://stock-news.laohu8.com/highlight/detail?id=2467854874","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467854874?lang=zh_cn&edition=full","pubTime":"2024-09-16 09:05","pubTimestamp":1726448712,"startTime":"0","endTime":"0","summary":"日前,华证指数公布了新一期的ESG评级结果,神威药业获得BBB评级,上一期ESG评级为BB。本期ESG评级在27家制药行业港股上市公司中排名第14。证券之星成立ESG生态联盟,旨在为上市公司和投资机构、ESG研究与评级机构等搭建沟通与交流平台,推动形成具有中国特色、国际认同的ESG管理体系。ESG 指标分别从环境、社会以及公司治理角度,来衡量企业发展的可持续性。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024091600000421.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159717","02877"],"gpt_icon":0},{"id":"2465756581","title":"南向资金9月4日净买入神威药业4.10万股 连续5日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2465756581","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2465756581?lang=zh_cn&edition=full","pubTime":"2024-09-05 09:30","pubTimestamp":1725499814,"startTime":"0","endTime":"0","summary":"9月4日, 南向资金增持神威药业4.10万股,连续5日增持。截止当日收盘,港股通共持有神威药业2588.90万股,占流通股3.12%。神威药业近5个交易日上涨4.22%,港股通累计增持124.70万股;近20个交易日上涨7.42%,港股通累计增持302.50万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409050931469ee1245a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409050931469ee1245a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","02877","BK1606"],"gpt_icon":0},{"id":"2464452693","title":"华兴证券:重申神威药业(02877)“买入”评级 目标价下调至18港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2464452693","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464452693?lang=zh_cn&edition=full","pubTime":"2024-09-04 14:48","pubTimestamp":1725432505,"startTime":"0","endTime":"0","summary":"华兴证券预计,神威药业(02877)2023至2026年间收入及纯利年均复合增长率分别达11%及10%。","market":"sh","thumbnail":"https://img.zhitongcaijing.com/image/20240904/20240904144844_91435.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20240904/20240904144844_91435.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1179119.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["161027","02877"],"gpt_icon":0},{"id":"2464390180","title":"《大行》华兴证券降神威药业(02877.HK)目标价至18元 每股净现金接近股价及维持高分红率","url":"https://stock-news.laohu8.com/highlight/detail?id=2464390180","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464390180?lang=zh_cn&edition=full","pubTime":"2024-09-04 11:21","pubTimestamp":1725420060,"startTime":"0","endTime":"0","summary":"华兴证券发表报告指,神威药业上半年营收在去年高基数下按年下滑,但净利润实现较高速增长。报告称,其每股净现金接近股价,维持高分红率。。截至6月底止,公司每股净现金为7.64元,等于最新收盘价的约87%。该行料其2023至2026年间收入及纯利年均复合增长率分别达11%及10%。华兴证券指,神威药业的中药配方颗粒下半年打后有望迎来复苏。该行认为神威药业的估值倍数理应至少等同于可比公司,由于公司的稳健增长前景和潜在的价值重估。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20210824152732002_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20210824152732002_s.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1379026/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["161027","02877"],"gpt_icon":0},{"id":"2464751391","title":"《大行》建银国际降神威药业(02877.HK)目标价至11元 上半年业绩逊","url":"https://stock-news.laohu8.com/highlight/detail?id=2464751391","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464751391?lang=zh_cn&edition=full","pubTime":"2024-09-04 10:07","pubTimestamp":1725415620,"startTime":"0","endTime":"0","summary":"建银国际发表报告指,神威药业上半年纯利升27%至6.26亿人民币(下同),撇除汇兑亏损、金融资产拨备亏损及一次性政府补贴因素后其盈利录4.48亿元按年下滑5%,上半年及次季收入分别按年跌各13%及20%至21亿元及9.69亿元,逊过预期。该行将神威药业目标价由12.3港元降至11港元,维持“跑赢大市”评级。该行亦认为,公司会保持今年至2026年的派息比率在42至43%水平,指公司今明两年的自由现金流会达8.1亿元及11亿元,足以支付年度派息率。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20210824152732362_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20210824152732362_s.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1378987/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02877"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.shineway.com.hk","stockEarnings":[{"period":"1week","weight":0.0072},{"period":"1month","weight":-0.1267},{"period":"3month","weight":0.0308},{"period":"6month","weight":-0.0044},{"period":"1year","weight":0.2591},{"period":"ytd","weight":0.2227}],"compareEarnings":[{"period":"1week","weight":-0.0217},{"period":"1month","weight":-0.0699},{"period":"3month","weight":0.0714},{"period":"6month","weight":0.0365},{"period":"1year","weight":0.0906},{"period":"ytd","weight":0.1234}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"中国神威药业集团有限公司是一家投资控股公司,主要从事研发、制造及营销现代中药业务。其主要产品包括注射液、软胶囊及颗粒剂。该公司的子公司包括远大国际有限公司、宏展国际有限公司和神威药业营销有限公司。","yearOnYearQuotes":[{"month":1,"riseRate":0.7,"avgChangeRate":0.036047},{"month":2,"riseRate":0.55,"avgChangeRate":0.036892},{"month":3,"riseRate":0.65,"avgChangeRate":0.024035},{"month":4,"riseRate":0.65,"avgChangeRate":0.050706},{"month":5,"riseRate":0.5,"avgChangeRate":0.035762},{"month":6,"riseRate":0.35,"avgChangeRate":-0.023615},{"month":7,"riseRate":0.15,"avgChangeRate":-0.066651},{"month":8,"riseRate":0.4,"avgChangeRate":-0.003101},{"month":9,"riseRate":0.35,"avgChangeRate":0.000151},{"month":10,"riseRate":0.65,"avgChangeRate":0.017311},{"month":11,"riseRate":0.45,"avgChangeRate":0.050127},{"month":12,"riseRate":0.526316,"avgChangeRate":-0.001599}],"exchange":"SEHK","name":"神威药业","nameEN":"SHINEWAY PHARM"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"神威药业(02877)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供神威药业(02877)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"神威药业,02877,神威药业股票,神威药业股票老虎,神威药业股票老虎国际,神威药业行情,神威药业股票行情,神威药业股价,神威药业股市,神威药业股票价格,神威药业股票交易,神威药业股票购买,神威药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"神威药业(02877)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供神威药业(02877)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}